硬化剂治疗后压迫治疗的系统综述
该系统综述旨在评估硬化剂治疗后压迫治疗的证据。结果显示,在C1期患者中任何时长的弹力袜压迫均显著减少毛细血管扩张和网状静脉的数量和大小;在C2-C6期患者中,不同压迫时长对临床症状或生活质量无显著差异,但35 mmHg弹力袜较23 mmHg显著改善泡沫硬化剂治疗后症状。证据在压迫类型、等级、长度和时长方面仍不足。
要点
- C1期患者液体硬化剂治疗后,任何时长弹力袜压迫均显著减少毛细血管扩张和网状静脉。
- C2-C6期患者液体或泡沫硬化剂治疗后,不同压迫时长对症状或生活质量无显著差异。
- C2期患者泡沫硬化剂治疗后,35 mmHg弹力袜较23 mmHg显著改善治疗后症状。
核心结论
- 硬化剂治疗后压迫可能在短期随访中带来有益临床结局。
- 关于压迫类型、等级、长度和时长的证据仍缺乏,需进一步试验指导优化管理。
研究设计与样本
- 纳入比较成人慢性静脉疾病患者接受液体或泡沫硬化剂治疗后压迫类型和/或时长的全文英文研究。
- 共识别9项研究:5项使用液体硬化剂,3项使用泡沫硬化剂,1项两者兼用。
主要发现
- 研究随访期短(6-24周),报告了临床结局、生活质量、副作用和并发症。
- 在C1期接受液体硬化剂治疗的患者中,任何时长的弹力袜使用与无压迫相比显著减少毛细血管扩张和网状静脉的数量和大小。
- 在C2至C6期患者中,比较液体或泡沫硬化剂治疗后压迫时长,临床症状或生活质量无显著差异。
- 在C2期接受液体硬化剂治疗至属支静脉的患者中,弹力袜较绷带显示更大的浅静脉消退。
- 在C2至C6期接受泡沫硬化剂治疗的患者中,使用35 mmHg弹力袜较23 mmHg弹力袜显著改善治疗后症状。
关键数值与推荐
- C1期液体硬化剂治疗后,任何时长弹力袜压迫显著减少毛细血管扩张和网状静脉数量和大小(与无压迫比较)。
- C2期液体硬化剂治疗至属支静脉,弹力袜较绷带显示更大浅静脉消退;弹力袜与绷带比较血栓性静脉炎发生率不同,但色素沉着无显著差异。
- C2至C6期泡沫硬化剂治疗后,35 mmHg弹力袜较23 mmHg弹力袜显著改善治疗后症状。
临床怎么用
- 对于C1期接受液体硬化剂治疗的患者,应考虑使用弹力袜压迫以减少毛细血管扩张和网状静脉。
- 对于C2至C6期患者,压迫时长对症状或生活质量的影响无显著差异,可根据个体情况选择。
- 在C2期液体硬化剂治疗至属支静脉时,弹力袜可能优于绷带用于浅静脉消退。
- 对于接受泡沫硬化剂治疗的C2至C6期患者,35 mmHg弹力袜可能较23 mmHg更有效改善症状。
局限性
- 结局测量异质性大。
- 压迫类型和时长的比较多种多样。
- 研究随访期短(6-24周)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Compression after sclerotherapy is commonly used, although the evidence base for this practice is unclear. This study aims to summarize and assess the evidence for compression therapy after sclerotherapy to inform clinical practice. METHODS: A systematic review was performed according to PRISMA guidelines via Medline and EMBASE databases (1946 to December 31, 2019) by two reviewers. Full-text, English-language studies comparing compression type and/or duration in adult chronic venous disease patients undergoing liquid or foam sclerotherapy were included. RESULTS: Nine studies were identified: five using liquid sclerotherapy, three foam sclerotherapy and one using both. Studies had short follow-up periods (6-24 weeks) and reported on clinical outcomes, quality of life, side effects and complications. In C1 patients undergoing liquid sclerotherapy, any duration of stocking use significantly decreased telangiectasia and reticular vein number and size compared with no compression. No significant difference in clinical symptoms or quality of life was seen when comparing compression duration after liquid or foam sclerotherapy in tributary or truncal veins in C2 to C6 patients. Greater superficial vein resolution was seen with stockings compared with bandages in C2 patients undergoing liquid sclerotherapy to tributary veins. A comparison of stockings vs bandaging revealed differing thrombophlebitis rates but no significant difference in pigmentation. In C2 to C6 patients undergoing foam sclerotherapy, use of 35 mm Hg stockings significantly improved post-treatment symptoms compared with 23 mm Hg stockings. This review was limited by heterogeneity of outcome measurements and the variety of comparisons between compression types and durations. CONCLUSIONS: Postsclerotherapy compression may have beneficial clinical outcomes at short-term follow-up; however, evidence is lacking regarding its type, class, length, and duration. Further trials are required to guide the optimal management of postsclerotherapy patients.
引用
- Tan MKH, Salim S, Onida S, et al. Postsclerotherapy compression: A systematic review. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32791308. doi:10.1016/j.jvsv.2020.07.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。